Skip to main content
Top
Published in: Clinical and Translational Oncology 3/2004

01-04-2004 | Revisiones

Prolonged neoadjuvant treatment plus GM-CSF in locally advanced breast cancer: clinical and biological concepts

Authors: Paula Raffin Pohlmann, Laura Suchil Bernal, Adolfo Fuentes Alburo, Jan Buter, Dolores Gallardo Rincón, Alejandro Mohar, Jose Ignacio Mayordomo, Jacobus J. M. van der Hoeven, Elsken van der Wall, Tanja D. de Gruijl, Herbert M. Pinedo

Published in: Clinical and Translational Oncology | Issue 3/2004

Login to get access
Metadata
Title
Prolonged neoadjuvant treatment plus GM-CSF in locally advanced breast cancer: clinical and biological concepts
Authors
Paula Raffin Pohlmann
Laura Suchil Bernal
Adolfo Fuentes Alburo
Jan Buter
Dolores Gallardo Rincón
Alejandro Mohar
Jose Ignacio Mayordomo
Jacobus J. M. van der Hoeven
Elsken van der Wall
Tanja D. de Gruijl
Herbert M. Pinedo
Publication date
01-04-2004
Publisher
Springer Milan
Published in
Clinical and Translational Oncology / Issue 3/2004
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/BF02710114

Other articles of this Issue 3/2004

Clinical and Translational Oncology 3/2004 Go to the issue

Announcement

Información

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine